| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.18 | 0.002 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.17 | 0.003 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.004 |